Engineered synthetic vesicles (
i.e. asymmetric liposomes) support comprehensive
in vitro studies on membrane organization and associated biological processes (
e.g. signaling, adhesion, protein transport, endocytosis, etc.). Membrane vesicles are spherical structures consisting of a single lipid bilayer enclosing an aqueous lumen. In nature, biological membranes possess many different lipid compositions with some degree of lipid asymmetry across the bilayer. A robust strategy for preparing customizable asymmetric vesicles will have a significant impact on basic and applied research in membrane biology because they more accurately represent the complexity of natural membranes. Here, we report a novel microfluidic-based fabrication process to build synthetic asymmetric vesicles while simultaneously controlling membrane unilamellarity, monodispersity, vesicle size, and luminal content.
Our microfluidic device consists of a triangular post region and two flow-focusing regions that can generate synthetic vesicles at high-throughput. The vesicle fabrication process has four steps: (1) generate highly monodispersed water-in-oil (w/o) emulsions in an oil/inner-leaflet-lipid solution that serve as precursors to form asymmetric vesicles based on the spontaneous assembly of lipid molecules; (2) replace the oil/inner-leaflet-lipid solution that surrounds the w/o emulsions with an oil/outer-leaflet-lipid solution inside the triangular post region; (3) form water-in-oil-in-water (w/o/w) double emulsions; and (4) extract excess oil/outer-leaflet-lipid solution from the double emulsions. Bilayer membrane asymmetry and unilamellarity are assessed by conducting a fluorescence quenching assay and an α-hemolysin (α-HL) protein insertion assay, respectively. Our approach addresses many of the deficiencies found in current technologies for building vesicles. This method enables us to observe the vesicle formation process on-chip (i.e. due to the transparency of the polydimethylsiloxane microfluidic device) and conduct off-chip experiments immediately after vesicle formation (i.e. since the last step for forming the vesicles occurs off-chip). Over 80% of the vesicles remained stable for at least 6 weeks and the membrane asymmetry was maintained for over 30 hours. The asymmetric vesicles built using this strategy are used to investigate fundamental properties of membranes, lipid-protein interactions, and can be used as drug delivery vehicles.